CARGO Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
CARGO Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2022 to Q3 2024.
  • CARGO Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$41.9M, a 18.1% decline year-over-year.
  • CARGO Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$154M, a 93.1% decline year-over-year.
  • CARGO Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$98.1M, a 140% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$154M -$41.9M -$6.44M -18.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$148M -$44.3M -$26.5M -148% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$121M -$35.8M -$23.1M -181% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$98.1M -$32.1M -$18.3M -133% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$79.8M -$35.5M -$23.2M -189% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$56.6M -$17.9M -$7.69M -75.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$48.9M -$12.7M -$7.99M -168% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$41M -$13.7M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$12.3M Jul 1, 2022 Sep 30, 2022 10-Q 2023-12-13
Q2 2022 -$10.2M Apr 1, 2022 Jun 30, 2022 10-Q 2023-12-13
Q1 2022 -$4.76M Jan 1, 2022 Mar 31, 2022 10-Q 2023-12-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.